Clinical Trials for Cutaneous Squamous Cell Carcinoma

Find clinical trials for cutaneous squamous cell carcinoma. Discover research opportunities and treatment options in your area.

23 Active Trials Found

Showing 23 trials on this page

Page 1 of 2

Sentinel Lymph Node Biopsy for Cutaneous Squamous Cell Carcinoma of the Head and Neck

NCT ID: NCT05108090

This clinical trial is exploring a specific type of biopsy called sentinel lymph node biopsy (SLNB) to see if it can effectively identify hidden tumor deposits in patients with cutaneous squamous c...

Recruiting

Phase: NA Type: interventional Locations: Indianapolis, Indiana, United States

MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors

NCT ID: NCT05076760

This clinical trial is exploring a new treatment called MEM-288, which is an oncolytic virus, either by itself or combined with another medication called nivolumab, for patients with advanced solid...

Recruiting

Phase: PHASE1 Type: interventional Locations: Durham, North Carolina, United States, Tampa, Florida, United States

Phase 2 Study of Ivonescimab in Patients With Cutaneous Squamous Cell Carcinoma

NCT ID: NCT06567314

This clinical trial is studying a new treatment called ivonescimab for patients with advanced cutaneous squamous cell carcinoma (cSCC), a type of skin cancer that is difficult to treat when it has ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Houston, Texas, United States, Houston, Texas, United States

Exercise to Boost Response to Checkpoint Blockade Immunotherapy

NCT ID: NCT06008977

This clinical trial is exploring whether exercising on the day of receiving immunotherapy can help improve the treatment response in patients with certain skin cancers, like melanoma, cutaneous squ...

Recruiting

Phase: NA Type: interventional Locations: Orlando, Florida, United States

Towards Cure Via Only Ultra-short ICB in CSCC

NCT ID: NCT06823479

This clinical trial, titled "Towards Cure Via Only Ultra-short ICB in CSCC," is exploring whether patients with cutaneous squamous cell carcinoma (CSCC) can be treated effectively using only immuno...

Recruiting

Phase: PHASE2 Type: interventional Locations: Utrecht, , Netherlands, Maastricht, Limburg, Netherlands +3 more

Intralesional Cemiplimab for Adult Patients With Cutaneous Squamous Cell Carcinoma or Basal Cell Carcinoma

NCT ID: NCT03889912

This clinical trial is studying a new treatment called cemiplimab for adults with two types of skin cancer: Cutaneous Squamous Cell Carcinoma (CSCC) and Basal Cell Carcinoma (BCC). The goal of the ...

Recruiting

Phase: PHASE1 Type: interventional Locations: Brisbane, Queensland, Australia, Houston, Texas, United States +31 more

A Beta-only IL-2 ImmunoTherapY Study

NCT ID: NCT05086692

This clinical trial, called the Beta-only IL-2 ImmunoTherapY Study, is looking to test a new treatment called MDNA11 for patients with advanced solid tumors, which are types of cancer that have spr...

Recruiting

Phase: PHASE1 Type: interventional Locations: San Diego, California, United States, Baltimore, Maryland, United States +28 more

A Phase 1B/2 Study of RP1 in Solid Organ Transplant Patients With Advanced Cutaneous Malignancies

NCT ID: NCT04349436

This clinical trial is investigating a new treatment called RP1 for patients who have had solid organ transplants and are facing advanced skin cancers, such as cutaneous squamous cell carcinoma, Me...

Recruiting

Phase: PHASE1 Type: interventional Locations: Ann Arbor, Michigan, United States, New York, New York, United States +21 more

Microneedle Array Plus Doxorubicin in Cutaneous Squamous Cell Cancer (cSCC)

NCT ID: NCT05377905

This clinical trial is testing a new treatment for cutaneous squamous cell carcinoma (cSCC), a type of skin cancer. The treatment involves using small patches with tiny needles that deliver a low d...

Recruiting

Phase: PHASE1 Type: interventional Locations: Pittsburgh, Pennsylvania, United States

ctDNA in Cutaneous Squamous Cell Carcinoma

NCT ID: NCT06875609

This clinical trial is exploring a new way to monitor patients with cutaneous squamous cell carcinoma (CSCC), a type of skin cancer, after they have had surgery. The researchers are testing a liqui...

Recruiting

Type: observational Locations: Boston, Massachusetts, United States

Study of the Monoclonal Antibody IMT-009 in Patients with Advanced Solid Tumors or Lymphomas

NCT ID: NCT05565417

This clinical trial is studying a new treatment called IMT-009, which is a monoclonal antibody being given to patients with advanced cancers, including types like non-small cell lung cancer, breast...

Recruiting

Phase: PHASE1 Type: interventional Locations: Denver, Colorado, United States, Sarasota, Florida, United States +11 more

Outcome Research of a European Registry Platform on Real-world Treatment Data of Patients with Advanced NMSC

NCT ID: NCT05741073

This clinical trial is looking at how patients with advanced non-melanoma skin cancer (NMSC), particularly Basal Cell Carcinoma (BCC) and Cutaneous Squamous Cell Carcinoma (cSCC), are treated in re...

Recruiting

Type: observational Locations: Brussels, , Belgium

Cutaneous Squamous Cell Carcinoma Staging Study

NCT ID: NCT05695222

The Cutaneous Squamous Cell Carcinoma Staging Study is a clinical trial aimed at improving how we predict the outcomes for patients with cutaneous squamous cell carcinoma (CSCC), which is a type of...

Recruiting

Type: observational Locations: London, , United Kingdom, London, , United Kingdom

FLASH Radiotherapy for Skin Cancer

NCT ID: NCT05724875

This clinical trial is looking at a new type of treatment called FLASH radiotherapy for patients with skin cancers, specifically Cutaneous Squamous Cell Carcinoma (cSCC) and Basal Cell Carcinoma (B...

Recruiting

Phase: NA Type: interventional Locations: Lausanne, Vaud, Switzerland

Phase I Study of Tolododekin Alfa (ANK-101) in Advanced Solid Tumors

NCT ID: NCT06171750

This clinical trial is studying a new treatment called ANK-101 for patients with advanced solid tumors, which are cancers that form lumps or masses in different parts of the body. The trial is in i...

Recruiting

Phase: PHASE1 Type: interventional Locations: Boston, Massachusetts, United States, Pittsburgh, Pennsylvania, United States +2 more

Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors

NCT ID: NCT04429542

This clinical trial is studying a new experimental drug called BCA101 to see how safe it is and how well it works on patients with certain types of advanced cancers that are driven by a protein cal...

Recruiting

Phase: PHASE1 Type: interventional Locations: Providence, Rhode Island, United States, Heidelberg, Victoria, Australia +18 more

Neoadjuvant Nivolumab and Relatlimab in Cutaneous Squamous Cell Carcinoma

NCT ID: NCT06288191

This clinical trial is looking at a new treatment approach for patients with cutaneous squamous cell carcinoma (cuSCC), a type of skin cancer. The study is testing two medications, nivolumab and re...

Recruiting

Phase: PHASE2 Type: interventional Locations: Wollstonecraft, New South Wales, Australia

In Situ Immunomodulation with CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients W/ Unresectable and Metastatic Solid Tumors

NCT ID: NCT04616248

This clinical trial is studying a new treatment approach for patients with certain types of advanced cancer that cannot be surgically removed. The treatment combines a medication called CDX-301, ra...

Recruiting

Phase: PHASE1 Type: interventional Locations: Buffalo, New York, United States, Los Angeles, California, United States +1 more

Evaluating the Use of Photodynamic Therapy to Treat Facial Cutaneous Squamous Cell Carcinoma in Situ (SCCis)

NCT ID: NCT06577311

This clinical trial is studying a new way to treat a specific type of skin cancer called cutaneous squamous cell carcinoma in situ (SCCis), which is an early form of cancer that develops in the upp...

Recruiting

Phase: PHASE2 Type: interventional Locations: Aventura, Florida, United States

Personalised Immunotherapy Platform

NCT ID: NCT06536257

This clinical trial, called the Personalised Immunotherapy Platform, is looking to improve treatment for patients with certain types of skin cancers, including melanoma and non-melanoma skin cancer...

Recruiting

Type: observational Locations: Sydney, New South Wales, Australia, Sydney, New South Wales, Australia +1 more

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions